ESR1 and breast carcinoma: Most of the studies recognized adiponectin as a negative regulator of cancer growth in ERα-negative breast cancers; while adiponectin at relatively low concentrations might sustain tumor development and progression in ERα-positive breast cancers [81,134,135,136,137,138,139,140,141,142].